Health Catalyst, Inc. (HCAT) Stock Price & Analysis
Health Catalyst, Inc. (HCAT) fell 2.01% to USD 1.71 as of June 10, 2026 at 03:47 UTC, according to Nexqual real-time market data.
HCAT last closed at USD 1.75; the session ranged USD 1.59–1.74 on volume of 1,997,139 shares. Market capitalization is $126.36M, with a 52-week range of USD 0.96–4.2 (NMS). Source: Nexqual, June 10, 2026 at 03:47 UTC.
Key Statistics (as of June 10, 2026 at 03:47 UTC)
| Price | USD 1.71 |
|---|---|
| Change | ▼ 2.01% (down) |
| Previous Close | USD 1.75 |
| Open | USD 1.73 |
| Day Range | USD 1.59 – 1.74 |
| 52-Week Range | USD 0.96 – 4.2 |
| Volume | 1,997,139 shares |
| Market Cap | $126.36M |
| Exchange | NMS |
Technical Analysis (HCAT)
Nexqual's technical model rates HCAT "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 03:47 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.77 (neutral) |
| vs SMA50 | Above (USD 1.34) |
| MACD | 0.1 (positive) |
Analyst Ratings (HCAT)
Wall Street analysts rate HCAT "Buy" based on 6 analysts, with a mean price target of USD 1.75 (range USD 1–2), per Nexqual as of June 10, 2026 at 03:47 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 1.75 |
| High Target | USD 2 |
| Low Target | USD 1 |
| Buy / Hold / Sell | 2 / 6 / 0 |
Earnings (HCAT)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD 0.03 |
| Revenue Estimate | $68.97M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.02 vs est 0.01 ▲ beat |
| 2025-12-31 | USD 0.08 vs est 0.1 ▼ miss |
| 2025-09-30 | USD 0.06 vs est 0.07 ▼ miss |
| 2025-06-30 | USD 0.04 vs est 0.04 ▲ beat |
Source: Nexqual, June 10, 2026 at 03:47 UTC.
Financials & Fundamentals (HCAT)
| Total Revenue | $302.48M |
|---|---|
| Revenue Growth (YoY) | -10.90% |
| Gross Margin | +50.44% |
| Operating Margin | -9.54% |
| Profit Margin | -87.70% |
| ROE | -103.02% |
| Debt / Equity | 123.48 |
| Current Ratio | 1.69 |
| Total Cash | $108.82M |
| Total Debt | $170.58M |
| Free Cash Flow | $23.99M |
Source: Nexqual, June 10, 2026 at 03:47 UTC.
Financial Health Score (HCAT)
Nexqual rates Health Catalyst, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:47 UTC.
| Growth | Mixed — Revenue +1.5% YoY (annual), slow |
|---|---|
| Profitability | Mixed — Gross margin 50%, operating -10% |
| Balance Sheet | Mixed — $109M cash vs $171M debt |
| Cash Flow | Solid — FCF $24M, 8% margin |
| Efficiency | Critical — ROE -103%, ROA -3.5% |
Ownership (HCAT)
| Insider Ownership | +5.19% |
|---|---|
| Institutional Ownership | +79.03% |
| Shares Outstanding | 73.89M |
| Float | 59.36M |
| Short % of Float | +11.00% |
Source: Nexqual, June 10, 2026 at 03:47 UTC.
Leadership (HCAT)
Health Catalyst, Inc. is led by Benjamin Albert (age 52), CEO & Director, per Nexqual as of June 10, 2026 at 03:47 UTC.
| CEO & Director | Benjamin Albert (age 52) |
|---|---|
| Chief Financial Officer | Jason Alger (age 41) |
| Chief Strategy Officer & Senior VP of Corporate Development | Kyle J. Salyers |
| Chief Marketing Officer | Carrie Kozlowski OT |
| Senior Vice President of International | Jeffrey P. Selander |
Major Backers & Investors (HCAT)
Notable institutional backers of Health Catalyst, Inc. include First Light Asset Management, LLC, Cdc Financial, Inc., Whetstone Capital Advisors, LLC, according to Nexqual as of June 10, 2026 at 03:47 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Light Asset Management, LLC | 17.43% |
| Cdc Financial, Inc. | 8.54% |
| Whetstone Capital Advisors, LLC | 5.78% |
| Palogic Value Management, LP | 3.92% |
| Impax Asset Management Group plc | 3.72% |
| IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund | 3.72% |
| Nepsis, Inc. | 2.54% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.9% |
| Vanguard Group | 8.15% |
| Geode Capital | 2.03% |
Source: Nexqual, June 10, 2026 at 03:47 UTC.
From Health Catalyst, Inc.'s Latest SEC 10-K Filing (filed 2026-03-12)
Key Strengths & Strategy (as disclosed to the SEC)
- Industry-agnostic analytics companies that help healthcare organizations develop homegrown solutions include IBM, Databricks, Snowflake, Microsoft, Tableau CRM, and Qlik.
- Our professional services experts combine industry-leading talent across multiple domain areas with a deep working knowledge of our technology to help our clients achieve a faster time-to-value and drive more meaningful and sustainable measurable improvements.
- Intellectual Property We rely on a combination of patent, trademark, and copyright laws in the United States as well as confidentiality procedures and contractual provisions to protect our intellectual property and trade secrets, including proprietary technology, databases, and our brand.
- Ignite has amassed large and comprehensive data assets, which enables us to deliver differentiated insights to our clients. • Applications.
Partnerships
- Our culture promotes an environment where team members trust each other, strive to continually learn, are motivated to lead hard-working yet balanced lives, make decisions with integrity and humility in mind, communicate openly and honestly, embrace teamwork and collaboration, and enjoy their days at work.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PHR | Phreesia, Inc. | USD 9.29 | ▼ 2.62% |
| LOB | Live Oak Bancshares, Inc. | USD 38.63 | ▲ 3.26% |
| HQY | HealthEquity, Inc. | USD 89.23 | ▲ 0.63% |
| PGNY | Progyny, Inc. | USD 25.83 | ▼ 0.12% |
| EVH | Evolent Health, Inc | USD 4.72 | ▲ 11.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:47 UTC. This page is informational and not investment advice.